TNF and pulmonary tuberculosis: In total, nine patients discontinued their TNF-α inhibitors due to adverse events: six experienced mild injection reaction, and they maintained low disease activity even after discontinuation, two patients were discontinued due to pulmonary tuberculosis, and one patient discontinued due to congestive heart failure.